A phase 2 single-arm study testing SBRT, adenosine signaling modulation, and immune checkpoint inhibition for men with hormone-sensitive oligometastatic prostate cancer (SBRT-AMICO).Kristine Peregrino Lacuna, Catherine S. Spina, Alexander Z. Wei et al.|Journal of Clinical Oncology|2024Cited by 0